Literature DB >> 35654366

Comparison of Outcomes From Delayed-Onset Bleb-Related Endophthalmitis Treated With Pars Plana Vitrectomy Versus Vitreous Biopsy.

Yasmin F K Islam1, Elizabeth A Vanner1, Syed G Khurshid2, Harry W Flynn1, David S Greenfield1.   

Abstract

PRCIS: Bleb-related endophthalmitis (BRE) is a serious complication of glaucoma filtration surgery. The current study reports similar visual and intraocular pressure (IOP) outcomes in eyes treated with pars plana vitrectomy (PPV) compared with vitreous biopsy and injection of intravitreal antibiotics (TI).
PURPOSE: The purpose of this study was to investigate the isolated organisms, visual acuity (VA), and IOP outcomes associated with delayed-onset BRE in eyes treated with PPV versus TI. PATIENTS AND METHODS: A retrospective chart review was conducted at the Bascom Palmer Eye Institute (Miami, Florida) and the University of Florida (Gainesville, FL) identifying patients treated for BRE with at least 1 month of follow-up from the inception of an electronic health record (2014 and 2011, respectively) through 2021. All patients had undergone bleb-forming glaucoma surgery at least 1 month before endophthalmitis diagnosis.
RESULTS: Thirty-nine eyes from 39 patients (33 from Bascom Palmer, 6 from University of Florida) were included. Trabeculectomy was performed in 34 of 39 eyes (87.2%). Streptococcus species (9 eyes, 23.1%) and Staphylococcus species (8 eyes, 20.5%) were the most common isolated organisms and were similar in both treatment groups ( P =0.49). Baseline VA was worse in the PPV group (logarithm of the minimum angle of resolution: 2.51 vs. 2.16, P =0.04), but VA at last follow-up was similar ( P =0.48) in both groups. After recovery from BRE, the average IOP in the PPV group was 15.1 mm Hg on 0.9 IOP-lowering medications compared with 12.6 mm Hg on 1.2 medications in the TI group (IOP: P =0.56; medications: P =0.80). Additional glaucoma surgery was performed in 44.4% of the PPV eyes and 16.7% of the TI eyes ( P =0.09).
CONCLUSION: In eyes with delayed-onset BRE, isolated organisms, visual outcomes, and IOP control were similar after initial PPV compared with TI.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35654366      PMCID: PMC9437113          DOI: 10.1097/IJG.0000000000002056

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.290


  13 in total

1.  Endophthalmitis after filtering surgery with mitomycin.

Authors:  D S Greenfield; I J Suñer; M P Miller; T A Kangas; P F Palmberg; H W Flynn
Journal:  Arch Ophthalmol       Date:  1996-08

2.  Complications following ex-press glaucoma shunt implantation.

Authors:  Richard M Stewart; James G Diamond; Emily D Ashmore; Ramesh S Ayyala
Journal:  Am J Ophthalmol       Date:  2005-08       Impact factor: 5.258

3.  Trabeculectomy-related complications in Olmsted County, Minnesota, 1985 through 2010.

Authors:  Jessica A Olayanju; Mohamed B Hassan; David O Hodge; Cheryl L Khanna
Journal:  JAMA Ophthalmol       Date:  2015-05       Impact factor: 7.389

Review 4.  Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes.

Authors:  Alice Song; Ingrid U Scott; Harry W Flynn; Donald L Budenz
Journal:  Ophthalmology       Date:  2002-05       Impact factor: 12.079

5.  Delayed-onset bleb-associated endophthalmitis (1996-2008): causative organisms and visual acuity outcomes.

Authors:  Theodore Leng; Darlene Miller; Harry W Flynn; David J Jacobs; Steven J Gedde
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

6.  Interim clinical outcomes in the collaborative bleb-related infection incidence and treatment study.

Authors:  Tetsuya Yamamoto; Yasuaki Kuwayama
Journal:  Ophthalmology       Date:  2010-10-08       Impact factor: 12.079

Review 7.  Antifibrotics and wound healing in glaucoma surgery.

Authors:  Paul J Lama; Robert D Fechtner
Journal:  Surv Ophthalmol       Date:  2003 May-Jun       Impact factor: 6.048

8.  Endophthalmitis After XEN Gel Stent Implantation: 2 Cases.

Authors:  Ali Olgun; Serhat Imamoğlu; Murat Karapapak; Eyüp Düzgün; Hakan Kaçar
Journal:  J Glaucoma       Date:  2018-12       Impact factor: 2.503

9.  Bleb-related endophthalmitis after trabeculectomy with mitomycin C.

Authors:  E J Higginbotham; R K Stevens; D C Musch; K O Karp; P R Lichter; T J Bergstrom; G L Skuta
Journal:  Ophthalmology       Date:  1996-04       Impact factor: 12.079

10.  Outcomes of Late-Onset Bleb-Related Endophthalmitis Treated with Pars Plana Vitrectomy.

Authors:  Kazuyoshi Ohtomo; Chihiro Mayama; Takashi Ueta; Miyuki Nagahara
Journal:  J Ophthalmol       Date:  2015-10-01       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.